Denmark Eliminates Leading Cancer-Causing HPV Strains Following 2008 Vaccine Rollout
By
slu
A second-rack bagel that's nearly first-rack. Tasty stuff.
Summary
Denmark has successfully eliminated infections from the two most dangerous cancer-causing HPV strains (types 16 and 18) following the introduction of the HPV vaccine in 2008. The research published in Eurosurveillance shows the vaccine program has been so effective that it provides protection even to unvaccinated women through herd immunity. This breakthrough could significantly impact future cervical cancer screening protocols as vaccinated populations grow.
Key quotes
· 4 pulledDenmark has effectively eliminated infections with the two biggest cancer-causing strains of human papillomavirus (HPV) since the vaccine was introduced in 2008
The research, published in Eurosurveillance, could have implications for how vaccinated populations are screened in the coming years
After breast cancer, cervical cancer is the most common type of cancer among women aged 15 to 44 years in Europe, and human papillomavirus (HPV) is the leading cause
Infections with human papillomavirus (HPV) types 16 and 18 have been virtually eliminated since vaccination began in 2008 – protecting even unvaccinated women
You might also wanna read
Google's Debug program seeks EPA approval to release 64 million modified mosquitoes in California and Florida
Google's Debug program plans to release up to 64 million genetically modified "good" mosquitoes in California and Florida over two years to
Researchers develop phage-based preventive treatment for newborn meningitis caused by E. coli K1
Researchers from the Biozentrum, University of Basel, and ETH Zurich have developed a novel preventive treatment for newborn meningitis caus
Daily pill daraxonrasib doubles survival for metastatic pancreatic cancer patients with KRAS mutation
A new daily pill called daraxonrasib has been shown to double survival time for metastatic pancreatic cancer patients with a KRAS mutation.
Exploring the science behind quantum effects in healthcare: separating research from pseudoscience
The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
